Dr. Gumbleton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
50 N Medical Dr
Salt Lake City, UT 84132Phone+1 801-581-2121
Education & Training
University of Utah HealthFellowship, Hematology and Medical Oncology, 2019 - 2023- University of Utah HealthResidency, Internal Medicine, 2018 - 2019
- University of Utah HealthInternship, Internal Medicine, 2017 - 2018
SUNY Upstate Medical UniversityClass of 2016
Certifications & Licensure
UT State Medical License 2018 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Augmenting Prognostication: Utilizing Activity Trackers to Enhance Survival Prediction in Metastatic Non-Small Cell Lung Cancer.Yeonjung Jo, Sonam Puri, Benjamin Haaland, Adriana M Coletta, Jonathan J Chipman
Clinical Lung Cancer. 2025-01-01 - Lichen striatus as an immune-related adverse event following ipilimumab/nivolumab and COVID-19 infection in an adult.Courtney M Kenyon, Brenna G Kelly, Anneli R Bowen, Matthew Gumbleton, Dekker C Deacon
JAAD Case Reports. 2024-10-01 - 2 citationsTTF-1 and immune checkpoint therapy in non-small cell lung cancer.Matthew Gumbleton, Eric L Snyder
Translational Lung Cancer Research. 2023-03-31
Press Mentions
Immunotherapy Demonstrates Potential for T-cell LymphomaOctober 11th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
